MDRS.F Stock Overview

A medical device company, develops, manufactures, and sells implant solutions worldwide. More details

MDRS.F fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	4/6
Past Performance	1/6
Financial Health	5/6
Dividends	0/6

Rewards

Earnings are forecast to grow 53.87% per year

Became profitable this year

Risk Analysis

Shares are highly illiquid

Large one-off items impacting financial results

Shareholders have been diluted in the past year

My Notes

Capture your thoughts, links and company narrative

Medartis Holding AG Competitors

Paragon 28

NYSE:FNA

US$866.5m

Axogen

NasdaqCM:AXGN

US$672.0m

Butterfly Network

NYSE:BFLY

US$852.2m

IRADIMED

NasdaqGM:IRMD

US$737.7m

Price History & Performance

Summary of share price highs, lows and changes for Medartis Holding
Historical stock prices
Current Share Price	CHF 51.70
52 Week High	CHF 84.10
52 Week Low	CHF 51.50
Beta	0.95
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	8.27%
Change since IPO	8.27%

Recent updates

Shareholder Returns

	MDRS.F	US Medical Equipment	US Market
7D	0%	1.0%	-2.1%
1Y	n/a	8.5%	21.3%

Return vs Industry: Insufficient data to determine how MDRS.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how MDRS.F performed against the US Market.

Price Volatility

Is MDRS.F's price volatile compared to industry and market?
MDRS.F volatility
MDRS.F Average Weekly Movement	n/a
Medical Equipment Industry Average Movement	8.2%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.8%
10% least volatile stocks in US Market	3.2%

Stable Share Price: MDRS.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine MDRS.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1997	860	Matthias Schupp	www.medartis.com

Medartis Holding AG, a medical device company, develops, manufactures, and sells implant solutions worldwide. Its medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. The company offers osteosynthesis instruments for the areas of the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for the areas of the mandible, midface, orthognathic, and cranium under the APTUS and MODUS names.

Medartis Holding AG Fundamentals Summary

How do Medartis Holding's earnings and revenue compare to its market cap?
MDRS.F fundamental statistics
Market cap	US$907.52m
Earnings (TTM)	US$4.41m
Revenue (TTM)	US$241.05m

205.0x

P/E Ratio

3.8x

P/S Ratio

Is MDRS.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MDRS.F income statement (TTM)
Revenue	CHF 220.28m
Cost of Revenue	CHF 42.89m
Gross Profit	CHF 177.40m
Other Expenses	CHF 173.36m
Earnings	CHF 4.03m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Mar 18, 2025

Earnings per share (EPS)	0.30
Gross Margin	80.53%
Net Profit Margin	1.83%
Debt/Equity Ratio	2.6%

How did MDRS.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 14:10
End of Day Share Price	2024/11/19 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Medartis Holding AG is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Eric Le Berrigaud	Bryan Garnier & Co
Hugo Solvet	Bryan Garnier & Co
Christoph Gretler	Credit Suisse

Medartis Holding OTCPK:MDRS.F Stock Report